Intrinsa Advisory Cmte. Decision Should Not Affect Dapoxetine, PPD Says
This article was originally published in The Pink Sheet Daily
Executive Summary
An FDA advisory committee's recommendation against approval of Procter & Gamble's testosterone patch Intrinsa should not impact Johnson & Johnson's premature ejaculation therapy dapoxetine, PPD says